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Key Messages
• Current methods of assessing colonic motility have significant limitations of expense, availability and patient
acceptability.
• We aimed to investigate the use of oral polyethylene glycol (PEG) electrolyte as standardized colonic
stimulation and magnetic resonance imaging (MRI) to monitor fluid distributions and gastrointestinal motility
noninvasively.
• Standard MRI, now widely available, showed that ingestion of PEG electrolyte solution increased the small
bowel water content fourfold.
• The size of the colon doubled after dosing and the ascending colon motility index rose markedly, the increase
being dose dependent.
• Such a challenge was well tolerated and could be a useful way of assessing colonic motility in future studies.
Abstract
Background Most methods of assessing colonic motil-
ity are poorly acceptable to patients. Magnetic reso-
nance imaging (MRI) can monitor gastrointestinal
motility and fluid distributions. We predicted that a
dose of oral polyethylene glycol (PEG) and electrolyte
solution would increase ileo-colonic inflow and
stimulate colonic motility. We aimed to investigate
the colonic response to distension by oral PEG elec-
trolyte in healthy volunteers (HVs) and to evaluate the
effect of single 2 L vs split (2 9 1 L) dosing. Methods
Twelve HVs received a split dose (1 L the evening
before and 1 L on the study day) and another 12 HVs a
single dose (2 L on the main study day) of PEG
electrolyte. They underwent MRI scans, completed
symptom questionnaires, and provided stool samples.
Outcomes included small bowel water content,
ascending colon motility index, and regional colonic
volumes. Key Results Small bowel water content
increased fourfold from baseline after ingesting both
split (p = 0.0010) and single dose (p = 0.0005). The
total colonic volume increase from baseline was
smaller for the split dose at 35  8% than for the
single dose at 102  27%, p = 0.0332. The ascending
colon motility index after treatment was twofold
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higher for the single dose group (p = 0.0103). Conclu-
sions & Inferences Ingestion of 1 and 2 L PEG
electrolyte solution caused a rapid increase in the
small bowel and colonic volumes and a robust rise in
colonic motility. The increase in both volumes and
motility was dose dependent. Such a challenge, being
well-tolerated, could be a useful way of assessing
colonic motility in future studies.
Keywords colon, intestinal fluid, motility, small
bowel, symptoms.
INTRODUCTION
Most current methods of assessing colonic motility are
invasive, involving intestinal intubation which is ardu-
ous for the patient and require a highly skilled investi-
gator.1 As such they are limited in their use to highly
selected patients.While ambulatorymanometry using a
radio-pill does allow non-invasive measurement of
motility, because its transit is uncontrolled it is not
possible to reliably assess any particular area of colon or
its response to stimulation.2 Furthermore without a
standard provocation, colonic motor activity shows
marked diurnal variation1,3 and repeated transit mea-
sures show poor reproducibility with 27–31% varia-
tion,4 suggesting variables like diet and activity alter
colonicmotility.Magnetic resonance imaging (MRI) can
non-invasively monitor gastrointestinal motility and
fluid distributions5–12 and may be suitable for assess-
ment of colonic function after an appropriate stimulus.
Oral polyethylene glycol (PEG) formulations have
been shown to be effective colonic stimulants at a 4 L
dose.13 Smaller volumes (2 L) of PEG-based solutions
containing ascorbic acid and electrolyte ions have
comparable efficacy and may be better tolerated.14–18
PEG is administered as a hyper-osmotic 402 mOsmol/
L non-nutrient solution. When given with the poorly
absorbed SO4
2 ion, it would therefore be expected to
generate a net inflow of fluid into the highly permeable
upper small intestine.19 As such, the solution would be
predicted to pass unabsorbed through the small bowel
causing a substantial increase in its fluid content
leading to an increased inflow into the colon distend-
ing the lumen and thereby stimulating motility. Until
recently there was no way of imaging serially and non-
invasively gastrointestinal fluid volumes, but recent
developments in MRI of gastrointestinal function
show that it is now feasible to provide functional
information on the gastrointestinal tract with both
excellent spatial and temporal characteristics.20 With
specific reference to gastrointestinal fluids, MRI has
been recently used to investigate fasting and postpran-
dial fluid distribution in health21,22 and disease8 and
also to investigate the mode of action of drugs such as
loperamide23 and a 5-HT3 antagonist.
24
Our hypothesis was that PEG electrolyte would
increase small bowel and colonic water content and
stimulate colonic motility which would be clearly
detectable with MRI imaging.
MATERIALS AND METHODS
Study design
This was an open-label, parallel group design study in healthy
volunteers (HVs) using MRI to compare the effects of a split,
2 9 1 L doses (separated by an overnight fast) vs one single 2 L
dose of PEG (Macrogol 3550) electrolyte solution (MOVIPREP;
Norgine Pharmaceuticals Ltd, Harefield, UK) given on the morn-
ing of the treatment day. This trial was registered on the EU
Clinical Trials Register with EudraCT Number 2010-021879-85.
There were no changes to the protocol. It was approved by the
National Research Ethics Service (approval 10/H0906/50), the
NHS Trust R&D (approval 10GA018), and by the Medicines and
Healthcare products Regulatory Agency (MHRA Clinical Trial
Authorization CTA 03057/0045/001-0001, protocol 10050). All
volunteers gave informed written consent before participating and
the studies were carried out to Good Clinical Practice standards.
Study product supplies and dispensing was organized by the
Clinical Trials Pharmacy of Nottingham University Hospitals.
Group 1 received 1 L of PEG electrolyte solution at 1 pm on
Day 1 and 1 L at 8 am the next morning on ‘Study day’. On each
occasion, they were allowed 1 h to drink the 1 L solution. Group 2
was given a single dose of 2 L PEG electrolyte solution at 8 am on
‘Study day’. They were allowed 2 h to drink the 2 L solution.
A range of gastrointestinal MRI parameters and stool character-
istics were assessed at baseline and at intervals as shown in Fig. 1.
This schematic diagram shows the timeline of each stool
collection, transit measurement, and MRI scans. It also shows
the timing of the split and single dosing. Whole gut transit was
assessed by giving the subjects inert MRI marker pills to ingest
24 h before undergoing a MRI transit scan. This was performed at
Day 8 and then again at Days 14 and 28. The subjects were asked
to provide samples of the first stool of the day at Day 1. The split
dose group later on the same Day 1 received the first PEG
electrolyte split dose, but the stool was provided before treatment.
Subjects underwent MRI scanning at intervals during the study
day. They attended again for morning scans at days 1, 3, 14, and 28
after purgation. They provided stool samples at Day 1, on the
‘Study day’, after dosing when the stool had become liquid and at
Day 14 and at Day 28. All baseline MRI scans were taken on the
study day after an overnight fast and before ingesting the PEG
electrolyte. Throughout the study, subjects completed a daily
Bristol Stool Diary,25 documenting bowel symptoms, stool fre-
quency, and consistency. The average of values from the stool
diary from Day 8 to Day 1 were taken to be ‘Pre-study week
average’ values.
Subjects
Twenty-four HVs were recruited from the general campus popu-
lation by advertisement. The inclusion criteria were male or
female, 18–65 years of age, body mass index (BMI) between 18 and
© 2014 The Authors.
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28 kg/m2. The exclusion criteria were pregnancy, any history of
serious acute or chronic illness especially gastrointestinal, use of
medication known to affect gastrointestinal transit, such as
opiates and constipating drugs, substance abuse, and unsuitability
for MRI scanning (such as having any contra-indicated metal
implants or pacemakers). Subjects were asked to avoid alcohol for
24 h before the study day. They were divided into two age–sex-
matched groups of 12 subjects. At enrollment, they all filled in a
Hospital Anxiety and Depression Scale,26 Perceived Stress27 and a
Patient Health Questionnaire 15.28 The demographic data are
given in Table S1.
Magnetic resonance imaging
The MRI scanning was carried out on a 1.5 T Philips Achieva
scanner (Philips Healthcare, Best, The Netherlands). Each volun-
teer was positioned supine in the scanner with a 4-element,
parallel imaging body coil wrapped around the abdomen. After
acquiring a scout scan to locate the position of the abdominal
organs, a range of MRI scans were taken. A balanced gradient echo
(balanced turbo field echo, BTFE) sequence with echo time
TE = 1.19 ms and repetition time TR = 2.4 ms was used to assess
gastric emptying. This comprised 20 transverse images with an in-
plane resolution of 1.56 mm 9 1.56 mm and slice thickness of
10 mm, with no gap between slices. A single shot, fast spin echo
sequence (similar to that used for MR cholangiopancreatography
[MRCP]) with effective TE = 320 ms was used to assess small
bowel water content.10 This comprised 24 coronal images with in-
plane resolution interpolated to 0.78 mm 9 0.78 mm and a slice
thickness of 7 mm, with no gap between slices (acquired voxel
size = 1.56 9 2.83 9 7 mm3). A dual gradient echo imaging
sequence (dual-echo fast field echo, FFE) with TE1 = 2.3 ms,
TE2 = 4.6 ms, and TR = 158 ms was used to visualize the anat-
omy. This comprised 24 coronal plane and 45 transverse images
with in-plane resolution 1.76 mm 9 1.76 mm and a slice thick-
ness of 7 mm, with no gap between slices. Each image set was
acquired on a single expiration breath-hold, the duration of which
varied between 13 and 24 s depending on the sequence. Including
set-up and imaging the volunteers spent ~15 min in the scanner
for every time point, spending the rest of the time sitting upright
in an adjacent room.
Ascending colon motility index
The motility of the ascending colon was assessed from a dynamic
‘cine’ MRI scan. This acquired a single, sagittal slice through the
ascending colon every second for 2 min, with the subjects simply
resting and breathing gently. The images were then used to
measure the ‘motility index score’ which was calculated by
dividing the ascending colon into three sections and calculating
the sum of the duration of contractions in minutes observed
multiplied by the number of sections of the ascending colon that
showed motility. Thus, if motility was observed involving the
whole ascending colon for 15 s and later involving only one-third
of the ascending colon for 20 s, the corresponding motility index
would be = (15 9 3) + (20 9 1) = 65 in units of segment 9 s.
Ascending colon chyme heterogeneity scores
The apparent heterogeneity of the ascending colon chyme was
graded by an experienced operator on high resolution images of
the ascending colon.23 The grading consisted in assigning a score
to the appearance of the chyme based on a predetermined score
card. The scores ranged between 1 (all dark) and 5 (all bright) with
3 having a mixture of dark and bright patches. This chyme
heterogeneity scoring system, which was developed in-house
using a mannitol model of diarrhea, has good inter-observer
(weighted kappa 0.82) and intra-observer (weighted kappa 0.84)
variability.29
Ascending colon chyme relaxation times T1
The longitudinal relaxation times (T1) of the ascending colon
chyme were measured from a single, sagittal slice through the
ascending colon using an Inversion Recovery balanced Turbo Field
Echo sequence with the following parameters: 1 sagittal slice, TR/
TE = 3.0/1.5 ms, field of view = 400 9 400 mm, matrix size
256 9 256, slice thickness = 10 mm, and eight different inversion
times (TI) ranging from 100 to 5000 ms. Each image was acquired
during a breath-hold with 15 s of free breathing between each
different TI to allow for full relaxation of the MRI signal. T1
reflects water proton mobility with cerebrospinal fluid having (at
1.5 T) a T1 of the order of 2400 ms and liver tissue a T1 of the
order of 500 ms. The appearance of the chyme was mostly
relatively uniform throughout the region but in two of the
subjects who took the single dose, the colonic contents appeared
to be divided between ‘brighter/wetter’ and ‘darker/drier’ con-
tents, suggesting a wash-in of watery ileal fluid which had not
mixed well with the thicker colonic contents. In this case, the
relaxation data reported are from the brighter/wetter region.
Abdominal symptoms
On the study day, the subjects were asked to complete 100 mm
VAS scales assessing their bowel sensation every time they came
out of the MRI scanner. The VASs assessed bloating, distension,
pain/discomfort, and nausea/sickness.
Figure 1 Schematic diagram of the study
protocol.
© 2014 The Authors.
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Whole gut transit time
The transit scans were carried out at three time points throughout
the study: 8 days before dosing (defined as Day 8), 14 days after
dosing, and 28 days after dosing. For each of these occasions, the
volunteers swallowed three inert MRI transit marker capsules,
with as much water as they desired, 24 h before the scan and
under the supervision of one of the study investigators. The inert
polyoxymethylene (POM) capsules (prescription pill shaped,
2.5 cm long with 1.0 cm diameter) were filled with water, traces
of Gadolinium contrast agent (0.2 mL of 15 lM Gd), and perfluo-
rooctyl bromide (PFOB, 0.6 mL) so that they would be visible both
on T1-weighted 1H proton MRI scans and on 19F fluorine MRI
scans. The dual-label transit marker pills were developed and
tested under separate Ethics approval G/05/2010. On the transit
measurement day, the volunteers attended the study center
having fasted overnight and a transit scan was performed.
A series of proton (1H) and fluorine (19F) images were acquired
on a 3T Philips Achieva scanner (Philips Healthcare) equipped
with a multinuclear channel and an abdominal fluorine MRI coil
(PulseTeq, Chobham, Surrey, UK) to localize the position of the
capsules in the gut. On the Days 14 and 28 of the protocol, the
transit measurements were performed first on the 3 T scanner and
immediately after that, all the other abdominal scans were
performed on the 1.5 T scanner. The transit was assessed by
scoring the position of the capsules according to previous gamma
scintigraphy methods with score 1 = in the small bowel,
2 = lower ascending colon, 3 = upper ascending colon, 4 = right
transverse colon, 5 = left transverse colon, 6 = descending colon,
7 = recto-sigmoid, and score 8 = expelled from the rectum. The
mean position was calculated to give a single final score. A recent
study using improved, smaller capsules showed that this measure
is moderately reproducible with a correlation between measures
repeated 1 week apart being 0.69,30 though there are outliers who
show up to 25 h differences in transit between assessments as
other have also found,31 variability which may in part reflect
genuine changes in transit with diet and other factors rather than
error in measurement. The method correlates well with the
standard radio-opaque marker technique of Metcalf, r = 0.85.32
Stool pH
The subjects were asked to provide samples of the first stool of the
day at Day 1 and at Day 14 and Day 28. They were also asked to
provide a sample on the main study day, after treatment when the
stool had become liquid. A small amount of the stool sample was
placed in a laboratory tube containing 3 mL distilled water with
pH = 7. The mixture was then shaken to break up the stool using
a bench vortex mixer (Fisher Scientific, Loughborough, UK) at a
medium speed, for around 10–15 s, or until there were no visible
solid pieces. The sample’s pH was then determined as an average
of two repeated measurement made using pH indicator strips
(Fisher Scientific).
Image analysis
Measurements of the volume of the gastric contents were carried
out on the axial images by manually tracing a region of interest
around the meal within the stomach on each image slice using
Analyze6 software (Biomedical Imaging Resource, Mayo Founda-
tion, Rochester, MN, USA) and summing across the slices to
determine the total volume at the different time points. The
surrounding organs and gastrointestinal gas were easily discrim-
inated and excluded from the region of interest.
The small bowel water content images were analyzed as
previously described.10 Briefly, regions of interest were drawn
manually around the small bowel on each of the MRCP images
excluding regions such as the stomach, gall bladder, and blood
vessels using in-house software on an IDL platform (IDL, Exelis
Visual Information Solutions, Boulder, CO, USA). The software
then calculated the number of voxels (a 3-dimensional dataset) in
each of the regions of interest with an intensity above a threshold
calibrated using the corresponding subject’s cerebrospinal fluid.10
Colonic volumes were measured by drawing manually on each
relevant slice of the coronal dual-echo fast field echo images on
Analyze9 software (Biomedical Imaging Resource, Mayo Founda-
tion). Separate regions of interest were drawn on the ascending,
transverse, and descending colon as described previously and then
summed across each dataset, yielding also the total colonic
volume as the sum of the three regions.33
Power and statistical analysis
The primary endpoint was the small bowel water content with
colonic water content, motility, and associated symptoms as
secondary endpoints. Previous work using mannitol and glucose8
showed that the small bowel water content was 47 mL (SD
15 mL) at 40 min postprandially after ingesting 300 mL glucose
solution. We calculated that we could detect an increase of 20 mL
in excess of this (which is very much less than that observed after
the mannitol challenge) with 90% power using n = 12 subjects.
The data are presented as mean  SEM. Normality of the data
was tested using Shapiro–Wilk’s test. The data were log trans-
formed to achieve normal distribution after which two-way
repeated measures ANOVA was used. Normal distribution of the
data was not achieved even after log transform for the ascending
colon motility index, chyme heterogeneity scores, and T1, or for
the abdominal symptoms on the MRI day. The temporal averages
for the two treatments on the study day were compared by
calculating the AUC from end of treatment to 4 h (AUC4h) using
the trapezoidal method. Comparisons between groups were
performed using two tailed unpaired t-test or Mann–Whitney’s
U-test, respectively. Correlations were assessed using Pearson’s
or Spearman’s test, respectively. Statistical analysis was carried
out using GraphPad Prism 5 (GraphPad Software Inc, La Jolla,
CA, USA). Differences were considered significant when
p < 0.05.
RESULTS
The two treatment groups were well matched for age,
gender, BMI, and psychological assessments (Table S1).
The study procedures were generally well-tolerated
with only one withdrawal from Group 1.
The MRI images showed clearly that as hypothe-
sized the ingestion of the PEG electrolyte solution
caused a rapid total increase in small bowel and colonic
water content (Fig. 2).
Small bowel water content
There was a significant effect of treatment on small
bowel water content (p = 0.0127, Table S2). Upon
dosing, the small bowel water content (shown in
© 2014 The Authors.
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Fig. 3) significantly increased fourfold from the fasting
baseline value for both the split dose (p = 0.0010) and
for the single dose (p = 0.0005). Peak small bowel water
content volumes ranged between 233 to 792 mL with
no difference between treatments (p < 0.8). Small
bowel water volumes returned to baseline values the
following day.
Colon volumes
Colonic volumes increased markedly upon dosing
(Fig. 4). As expected after treatment, the increase in
total colonic volumes from baseline values was
smaller for the 1 L split dose at 35  8% (range
0–81%) than for the single 2 L dose at 102  27%
(range 9–289%) p = 0.0332. The largest changes were
found in the ascending and transverse colon with
little change in the descending colon, although most
subjects defecated during the study showing the
solution had passed through the descending colon.
The ascending colon volumes were significantly
greater with the 2 L dose, p = 0.0099 (Table S2). The
volumes gradually returned to baseline values toward
the end of the study day.
Ascending colon motility index
The baseline ascending colon motility index (Fig. 5)
was close to zero for most subjects. Both dosing
regimens induced marked increases in ascending
colon motility in all subjects. After treatment, the
motility index was twofold higher for the single 2 L
dose compared with the 1 L split dose group
(p = 0.0103). The scores were numerically higher for
the single dose throughout the study day though the
difference in AUC4h was not statistically significant
A
B
C
D
E
F
Figure 2 Representative anatomical images
(upper panel) and bowel water images (lower
panel) for a subject that drank a single 2 L
PEG electrolyte dose. (A) and (B) were
acquired at fasting baseline before dosing. In
(B), a small amount of fluid can be seen in
the small bowel, the transverse colon
appears very dark, and the stomach shows
the presence of limited resting fluid. The
other images (C–F) were taken immediately
after the subject completed the 2 L PEG
electrolyte dose (2 h after starting the drink).
(D) It shows the small bowel full of bright
fluid and a marked distension of the cecum
and transverse colon, both full of bright
fluid. (F) is from a more posterior image
plane and shows the marked distension of
the ascending and descending colon, also
both full of bright fluid.
Figure 3 Small bowel water content (SBWC) for the group of 11
healthy volunteers who took the split 2 9 1 L dose of PEG electrolyte
and the separate group of 12 healthy volunteers who took the single
2 L dose of PEG electrolyte. Values are mean volume (mL) SEM.
© 2014 The Authors.
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(Table S3). The peak change from baseline values in
ascending colonic motility index correlated positively
and significantly with change from baseline values in
ascending colon volume, Spearman’s r = 0.53,
p = 0.0128 (Fig. 6). Removing the outlier at 800 mL
change in ascending colon volume from baseline does
not change the Spearman’s correlation r = 0.53,
p = 0.0161. Two ascending colon motility MRI mov-
ies are shown in Supporting Information (Movie S1
and S2).
Ascending colon chyme heterogeneity scores
The baseline ascending colon chyme heterogeneity
scores (shown in Fig. 7A) for the split dose 2.6  0.2
were significantly higher than those for the baseline of
A B
C D
Figure 4 Regional anatomical volumes of the (A) ascending, (B) transverse, and (C) descending colon for the group of 11 healthy volunteers who took
the split 2 9 1 L dose of PEG electrolyte and the separate group of 12 healthy volunteers who took the single 2 L dose of PEG electrolyte. (D) The
corresponding total colonic volume. Values are mean volume (mL) SEM.
© 2014 The Authors.
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the single dose group 1.8  0.2 (p = 0.0198; Fig. 7B).
On the study day the scores doubled after dosing
compared to baseline for both the split
dose (p = 0.0003) and the single dose (p <
0.0001), they remained sustained throughout the
study day and returned to baseline the following day.
Ascending colon chyme relaxation times T1
The baseline value of ascending colon chyme T1 for
the split dose was significantly higher than of the
single dose group, p = 0.0496 (Fig. 8). The T1 signifi-
cantly increased fourfold from baseline values upon
dosing for both the split dose (p < 0.0004) and the
single dose (p < 0.0005). The split dose T1 values
remained higher than for the single dose throughout
the study day, but the difference was not significant
(Table S3). The T1 values returned to baseline values
the following day.
Gastric volumes
At the first imaging point taken immediately after the
period allowed for drinking the volume of liquid
remaining in the stomach was comparable between
groups (524  80 mL for the split dose group vs
449  63 mL for the single dose group, p = 0.4665),
despite the difference in volumes consumed.
Abdominal symptoms
Abdominal symptoms on the study day were mild in
this healthy population. Symptoms rose immediately
upon dosing and declined during the study day return-
ing to baseline values (Figure S1). The split dose had
consistently lower AUC4h values than the single dose,
but there were no significant differences in symptoms
between the two dosing regimens (Table S3).
Correlations of MRI bowel parameters with
abdominal symptoms
There was a relatively weak but significant correlation
between the peak change from baseline feeling of
bloating and the change from baseline small bowel
water content (Spearman’s r = 0.47, p = 0.0231, Fig-
ure S2A), but the correlation with change from base-
line total colon volume was not significant (Spearman
r = 0.11, p = 0.6345, Figure S2B). Similarly, peak
change from baseline feeling of distension correlated
with change from baseline small bowel water content.
This correlation was again relatively weak but signif-
icant (Pearson’s r = 0.44, p = 0.0371, Figure S2C). The
correlation with change from baseline total colonic
volume was not significant (Spearman’s r = 0.31,
p = 0.1675, Figure S2D).
Whole gut transit time
The mean position score of the MRI marker pills was
not different between the groups allocated to split dose
or single dose at Day 8 (6.2  0.4 vs 5.4  0.6,
p = 0.2527), at Day 14 (5.8  0.4 vs 5.5  0.5,
p = 0.6076), or at Day 28 (6.1  0.5 vs 6.6  0.3
Figure 5 Ascending colon motility index for the group of 11 healthy
volunteers who took the split 2 9 1 L dose of PEG electrolyte and the
separate group of 12 healthy volunteers who took the single 2 L dose of
PEG electrolyte. Values are mean Motility Index (segment 9 second)
SEM.
Figure 6 Correlation between peak change from baseline ascending
colon motility index (values are in segment 9 second) and change
from baseline ascending colon volume (values are in mL). Data are
from both groups of healthy volunteers who took the split 2 9 1 L
dose or the single 2 L dose of PEG electrolyte.
© 2014 The Authors.
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respectively, p = 0.3327). Pooling the data from both
treatment together shows no difference in whole gut
transit between Days 8 and 14 after treatment
(p = 0.7750) or Day 28 after treatment (p = 0.2350).
Stool frequency, consistency, and pH
The frequency of bowel movements (Figure S3A)
increased sevenfold from baseline on the treatment
study day for both the split dose (p < 0.0001) and the
single dose (p = 0.0025) with no difference between
treatments (p = 0.7075). Stool frequency returned to
baseline values the following day.
Stool consistency scores (Figure S3B) doubled on the
treatment study day to virtually liquid stool for both
the split dose (p = 0.0089) and the single dose
(p = 0.0005). The consistency scores on the study day
were marginally but significantly higher for the single
dose treatment (p = 0.0236). Stool consistency scores
reduced but remained elevated (i.e., softer) compared to
baseline (average for Days 8 to Day 1) on Day 1 and
Day 3 though the differences from baseline were not
significant (p = 0.4–1). Stool consistency scores
returned to baseline at Day 14.
Stool pH increased significantly from baseline
7.0  0.1 to pH 7.9  0.1 after dosing for both the
split dose (p < 0.0003) and the single dose (p < 0.0002).
There was no difference between treatments (p < 0.7).
The stool pH returned to baseline values at Days 14
and 28.
DISCUSSION
Ingestion of the low-dose PEG electrolyte solution
either as a single dose or a split dose caused a rapid
increase in small bowel and colonic fluid content, and
a marked increase in colon volumes and motility.
Gastric emptying of this non-nutrient meal was rapid
and driven by gastric distension. However, the fluid
volumes in the small bowel were similar in the first
postprandial scan for both the 1 and 2 L dose
suggesting that it was maximally distended by the
1 L so that increased input with the 2 L dose led to
more rapid evacuation into the colon. The right colon,
A
B
Figure 7 Heterogeneity scores of the
appearance of the ascending colon chyme on
high resolution sagittal MRI images. (A) The
scoring card with scores ranging from 1 (all
dark materials) to 5 (all bright fluid) and 3
having a mixture of dark and bright regions.
(B) Heterogeneity scores for the group of 11
healthy volunteers who took the split
2 9 1 L dose of PEG electrolyte and the
separate group of 12 healthy volunteers who
took the single 2 L dose of PEG electrolyte.
Values are the operator’s heterogeneity
scores SEM.
© 2014 The Authors.
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in keeping with its major role as a region where
fermentation of unabsorbed carbohydrate takes place
prior to absorption, is better able to accommodate the
increased input which is reflected in the increase in
ascending colon volume. However, as others have
shown34 rapid input overwhelms the absorptive capac-
ity, distending the ascending colon leading to greater
motor response with increasing inflow. The vigorous
contractions, which could be clearly seen on cine
imaging, explain why the transverse colon volume
was also increased as fluid was propelled distally.
These two proximal regions of the colon appeared able
to accommodate the increased load at least for the
first 2 h. Thereafter, many subjects defecated which
prevented the total colon volume increasing beyond
an average of 1.2 L. It is worth noting that, in keeping
with the descending colon’s largely propulsive rather
than accommodative function, its volume did not
increase, although the chyme passed through this
region as shown by the fact that most subjects
defecated within 1–2 h of PEG ingestion. The sensa-
tion of bloating, distension, discomfort, and nausea all
peaked immediately after ingestion and then declined
being close to baseline within 2 h suggesting a mainly
upper gut origin. Our finding that bloating correlated
better with small bowel, but not colon volumes with
a steeper rise in symptoms for any given rise in
volume supports idea that the right colon is better
able to adapt to increased volume than the small
bowel.
These were HVs and the effect on patients with
functional gastrointestinal disease and associated vis-
ceral hypersensitivity remains to be investigated but
we do know that in IBS-D there appears to be less
postprandial accommodation of the ascending colon33
which may account for the associated faster colonic
transit. Preliminary studies in constipated individuals
show that some show impaired motility response and
enhanced symptoms with PEG electrolyte challenge
and this is subject of ongoing research. Previous
scintigraphic studies have also suggested that rapid
clearance of the ascending colon correlates with
increased stool weight and faster overall transit in
IBS-D.35 The stimulation of colonic motility was
greater for the 2 L single dose in keeping with the
greater distension induced, but the effect on small
bowel motility was not assessed.
Both dosing regimens increased ascending colon
chyme heterogeneity scores, T1 relaxation times, and
had a marked effect on stool pH postpurging. An
increase in T1 relaxation times measured posttreat-
ment, with values approaching the T1 of free water,
reflects the dilution of colonic contents.
The alkalinization of stool we found is a feature of
other diarrheal conditions and reflects loss of the short
chain fatty acids produced by the colonic microbiota
allowing the normally alkaline ileal contents to pass
unaltered through the impermeable colon.
Many studies of bowel cleansing prior to colonos-
copy have shown the effectiveness of 2 L of PEG-based
solutions with ascorbic acid.14–18 There is also some
evidence that taking the smaller volume in two split
1 L doses may be advantageous giving better bowel
cleansing but similar tolerability.36 The lesser disten-
sion of the ascending and transverse colon was asso-
ciated with numerically lower symptom scores, but
this difference was not significant in our HVs, probably
because they evacuated fluid rapidly per rectum,
preventing excessive colonic distension with the
higher dose.
In conclusion, this imaging study has shown for the
first time the changes in intestinal fluid after oral PEG
electrolyte bowel preparation. PEG electrolyte caused a
rapid fluid volume increase in the small bowel and in
the right side of the colon, stimulating colonic motility
and propulsion of the PEG electrolyte through the
colon. The technique is well-tolerated and pilot data
suggest that this colonic stimulation can provide a
patient acceptable way to distinguish different degrees
of colonic responsiveness which are likely to
Figure 8 Ascending colon chyme longitudinal relaxation time T1 for
the group of 11 healthy volunteers who took the split 2 9 1 L dose of
PEG electrolyte and the separate group of 12 healthy volunteers who
took the single 2 L dose of PEG electrolyte. Values are mean relaxation
time T1 (in seconds) SEM.
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characterize disorder of colonic function like constipa-
tion and diarrhea.
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